Stanford Medical School Shield
 
ARAMIS button
investigators button
research button
publications button
HAQ button
pharmaceutical collaborations button
 
Link to Main Stanford Medical School Site
 Heading Filler Publications Page Heading
Clear Spacer  
 

    1996

  • Britton CA, Wasko MC. Rheumatoid arthritis. Semin Roentgenol. 1996;31(3):198-207.
  • Callahan LF, Cordray DS, Wells G, Pincus T. Formal education and five-year mortality in rheumatoid arthritis: mediation by helplessness scale score. Arthritis Care Res. 1996;9(6):463-72.
  • Fries J. Toward an understanding of NSAID-related adverse events: the continuation of longitudinal data. The Scandinavian Jnl of Rheumatology. 1996;102:3-8.
  • Fries J. Non-steroidal anti-inflammatory drug safety: a view from the ARAMIS databank. Current Opinions in Rheumatology. 1996;8 (suppl 1):S3-S7.
  • Fries JF. Effectiveness and toxicity considerations in outcome directed therapy in rheumatoid arthritis. J Rheumatol Suppl. 1996;44:102-6.
  • Fries JF. Selective cyclooxygenase inhibition: promise for future NSAID therapy? Scand J Rheumatol Suppl. 1996;102(1):1.
  • Fries JF. Prevention of osteoporotic fractures: possibilities, the role of exercise, and limitations. Scand J Rheumatol Suppl. 1996;103:6-10.
  • Fries JF. Physical activity, the compression of morbidity, and the health of the elderly. J R Soc Med. 1996;89(2):64-8.
  • Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum. 1996;39(4):616-22.
  • Gironimi G, Clarke AE, Hamilton VH, et al. Why health care costs more in the US: comparing health care expenditures between systemic lupus erythematosus patients in Stanford and Montreal. Arthritis Rheum. 1996;39(6):979-87.
  • Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta- analysis. Bmj. 1996;312(7046):1563-6.
  • James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RK. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study. Stat Med. 1996;15(13):1421-34.
  • Jones M, Symmons D, Finn J, Wolfe F. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. British Journal of Rheumatology. 1996;35:738-45.
  • Khraishi MM, Singh G. The role of anti-malarials in rheumatoid arthritis--the American experience. Lupus. 1996;5 Suppl 1:S41-4.
  • Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med. 1996;101(2):129-34.
  • Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100(2):193-6.
  • Michel BA, Arend WP, Hunder GG. Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. J Rheumatol. 1996;23(1):106-11.
  • Minor MA, Lane NE. Recreational exercise in arthritis. Rheum Dis Clin North Am. 1996;22(3):563-77.
  • Pincus T. Documenting quality management in rheumatic disease: are patient questionnaires the best (and only) method? Arthritis Care Res. 1996;9(5):339-48.
  • Pincus T, Griffith J, Pearce S, Isenberg D. Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol. 1996;35(9):879-83.
  • Plesh O, Wolfe F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity. J Rheumatol. 1996;23(11):1948-52.
  • Sampalis JS, Medsger TA, Fries JF, et al. Risk factors for adult Still's disease. J Rheumatol. 1996;23(12):2049-54.
  • Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med. 1996;156(14):1530-6.
  • Singh G, Terry R, Ramey D, Wolfe F, Fries J. Long-term medical costs and outcomes are significantly asociated with early changes in disability in rheumatoid arthritis. Arthritis Rheum. 1996;39:S318.
  • Star VL, Scott JC, Sherwin R, Lane N, Nevitt MC, Hochberg MC. Validity of self-reported rheumatoid arthritis in elderly women. J Rheumatol. 1996;23(11):1862-5.
  • Superio-Cabuslay E, Ward M, Lorig K. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal anti-inflammatory drug treatment. Arthritis Care and research. 1996;9:292-301.
  • Ward MM. Assessing the relative sensitivity to change of rheumatoid arthritis activity measures: is the type of treatment an important third variable? J Clin Epidemiol. 1996;49(10):1161-9.
  • Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med. 1996;156(12):1337-44.
  • Williams C, Bloch D, Sibley J. Lymphoma and leukemia in rheumatoid arthritis: are they associated with azathioprine, cyclophosphamide, or methotrexate? A matched case-control study in the Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS) population. J Clin Rheumatol. 1996;2:64-72.
  • Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl. 1996;44:13-22.
  • Wolfe F. The fibromyalgia syndrome: a consensus report on fibromyalgia and disability. J Rheumatol. 1996;23(3):534-9.
  • Wolfe F, Hawley DJ, Peloso PM, Wilson K, Anderson J. Back pain in osteoarthritis of the knee. Arthritis Care Res. 1996;9(5):376-83.
  • Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996;23(8):1407-17.
  • Wolfe F, Potter J. Fibromyalgia and work disability: Is Fibromyalgia a disabling disorder? Rheum Dis Clin North Am. 1996;22(2):369-91.
 

ARAMIS |  Investigators |  Research |  Publications |  HAQ |  Pharmaceutical Collaborations

©2001 Stanford University. All Rights Reserved. If you experience any difficulty with this site, please email our webmaster. Last updated October 2001.